Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

2,307

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

Diagnostic test for SARS-Cov2 for patients and health staff

"Diagnostic test for SARS-CoV2 :~* Blood test to analyse the IgG and IgM with an immediate qualitative analysis (serological test) and a differed quantitative analysis (ELISA test)~* Results of nasal swab that will allow extracting the RNA and realizing a RT-PCR (only if the participants present symptoms). It will be obtained by standard local laboratories.~* Questionnaires (based on serology, clinic, economy (socio-demographic and lifestyle questionnaire) and epidemiology)"

Trial Locations (3)

49055

Institut de Cancerologie de l'Ouest, Angers

54511

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

63011

Centre Jean Perrin, Clermont-Ferrand

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT04421625 - Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic | Biotech Hunter | Biotech Hunter